Compounds > glucose, (beta-d)-isomer
Page last updated: 2024-08-24

glucose, (beta-d)-isomer and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

glucose, (beta-d)-isomer has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, CL; Busse, WW1
Claesson, HE; Lundberg, U; Malmsten, C1
Anderson, CL; Busse, WW; Cooper, W1
Carcillo, JA; Herzer, WA; Jackson, EK; Mi, Z; Thomas, NJ1

Other Studies

4 other study(ies) available for glucose, (beta-d)-isomer and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone

ArticleYear
The granulocyte response to the phosphodiesterase inhibitor RO 20-1724 in asthma.
    The Journal of allergy and clinical immunology, 1981, Volume: 67, Issue:1

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Asthma; Cyclic AMP; Dose-Response Relationship, Drug; Glucuronidase; Granulocytes; Humans; Imidazoles; Lysosomes; Neutrophils; Phosphodiesterase Inhibitors; Zymosan

1981
Serum-coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes. Inhibition by cyclic AMP.
    Biochemical and biophysical research communications, 1981, Apr-30, Volume: 99, Issue:4

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Arachidonic Acids; Chromatography, High Pressure Liquid; Cyclic AMP; Epoprostenol; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Leukotriene B4; Neutrophils; Zymosan

1981
Cortisol protection of the granulocyte response to isoproterenol during an in vitro influenza virus incubation.
    The Journal of allergy and clinical immunology, 1981, Volume: 67, Issue:3

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adult; Female; Glucuronidase; Granulocytes; Histamine; Humans; Hydrocortisone; Influenza Vaccines; Isoproterenol; Male; Orthomyxoviridae; Prostaglandins E; Zymosan

1981
Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adrenergic alpha-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Male; Multiple Organ Failure; Norepinephrine; Phosphodiesterase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Circulation; Splanchnic Circulation; Vascular Resistance; Zymosan

2001